| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
2,232 |
2,129 |
$61K |
| 80050 |
General health panel |
1,538 |
1,491 |
$59K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
1,017 |
937 |
$47K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
1,017 |
939 |
$31K |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
1,743 |
1,671 |
$30K |
| 84443 |
Thyroid stimulating hormone (TSH) |
1,768 |
1,685 |
$30K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
3,802 |
3,524 |
$28K |
| 86780 |
|
1,553 |
1,484 |
$20K |
| 80061 |
Lipid panel |
1,608 |
1,552 |
$20K |
| 86769 |
|
579 |
517 |
$20K |
| 88142 |
|
811 |
769 |
$19K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
2,013 |
1,935 |
$18K |
| 84481 |
|
1,056 |
1,009 |
$18K |
| 87088 |
|
2,282 |
2,094 |
$17K |
| 80053 |
Comprehensive metabolic panel |
1,697 |
1,579 |
$17K |
| 86762 |
|
1,016 |
964 |
$15K |
| 84403 |
|
589 |
558 |
$14K |
| 87624 |
Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types |
434 |
398 |
$14K |
| 87340 |
|
1,293 |
1,239 |
$13K |
| 82607 |
|
862 |
785 |
$13K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
762 |
200 |
$11K |
| 84439 |
|
1,158 |
1,108 |
$9K |
| 82670 |
|
337 |
326 |
$9K |
| 86803 |
|
617 |
588 |
$9K |
| 86850 |
|
1,288 |
1,235 |
$8K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
280 |
242 |
$8K |
| 83001 |
|
419 |
401 |
$8K |
| 87077 |
|
749 |
699 |
$8K |
| 86376 |
|
435 |
415 |
$6K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
863 |
806 |
$6K |
| 82950 |
|
943 |
881 |
$5K |
| 80320 |
|
257 |
70 |
$4K |
| 82105 |
|
232 |
226 |
$4K |
| 84702 |
|
258 |
181 |
$4K |
| 86901 |
|
1,130 |
1,080 |
$4K |
| 86900 |
|
1,129 |
1,079 |
$4K |
| 87186 |
|
653 |
612 |
$3K |
| 87070 |
|
223 |
213 |
$3K |
| U0004 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r |
46 |
45 |
$3K |
| 82728 |
|
270 |
257 |
$3K |
| 84436 |
|
465 |
445 |
$3K |
| 80074 |
|
59 |
58 |
$3K |
| 84270 |
|
103 |
96 |
$2K |
| 83550 |
|
257 |
240 |
$2K |
| 83540 |
|
305 |
292 |
$2K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
35 |
33 |
$2K |
| 82746 |
|
178 |
162 |
$2K |
| 87480 |
|
48 |
44 |
$1K |
| 81001 |
|
325 |
307 |
$1K |
| G0103 |
Prostate cancer screening; prostate specific antigen test (psa) |
59 |
57 |
$985.68 |
| 87660 |
|
48 |
44 |
$983.62 |
| 83002 |
|
68 |
65 |
$875.46 |
| 84480 |
|
90 |
88 |
$857.41 |
| 86592 |
|
208 |
194 |
$854.86 |
| 84146 |
|
54 |
51 |
$774.70 |
| 82570 |
|
98 |
88 |
$712.40 |
| 87510 |
|
35 |
32 |
$668.36 |
| 86140 |
|
119 |
117 |
$487.79 |
| 83013 |
|
31 |
29 |
$470.85 |
| 86706 |
|
28 |
28 |
$451.63 |
| 84550 |
|
83 |
77 |
$371.46 |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
13 |
13 |
$359.31 |
| 88304 |
|
26 |
24 |
$310.27 |
| 84144 |
|
14 |
12 |
$287.56 |
| 85651 |
|
75 |
71 |
$269.99 |
| 36415 |
Collection of venous blood by venipuncture |
2,710 |
2,415 |
$112.55 |
| 82043 |
|
19 |
17 |
$102.96 |
| 84156 |
|
41 |
38 |
$77.34 |
| 85027 |
|
14 |
12 |
$75.88 |
| 81511 |
|
29 |
29 |
$0.00 |